|
Kaski JC, Consuegra-Sanchez L. PERTINENT (a substudy of the EUROPA trial): a persistent legacy. Cardiovasc Res. 2012 Nov 1;96(2):202-3; discussion 204-7. doi: 10.1093/cvr/cvs178. PubMed PMID: 22815531.
AÑO: 2012; IF: 5.94
|
22815531
|
Félix-Redondo FJ, Fernández-Bergés D, Calderón A, Consuegra-Sánchez L, Lozano L, Barrios V. Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study. J Hypertens. 2012 Jul;30(7):1460-7. doi: 10.1097/HJH.0b013e3283546719. PubMed PMID: 22573128.
AÑO: 2012; IF: 3.806
|
|
Dominguez-Rodriguez A, Consuegra-Sanchez L, Blanco-Palacios G, Abreu-Gonzalez P, Sanchez-Grande A, Bosa-Ojeda F, Kaski JC. Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study. Int J Cardiol. 2012 Jun 28;158(1):160-2. doi: 10.1016/j.ijcard.2012.04.076. PubMed PMID: 22560915.
AÑO: 2012; IF: 5.509
|
|
Fernández-Bergés D, Félix-Redondo FJ, Consuegra-Sánchez L, Galán Montejano M. [Are the CHADS(2) and CHA(2)DS(2)-VASc scales useful instruments to initiate anticoagulant medication?]. Rev Clin Esp. 2012 Sep;212(8):418-9. doi: 10.1016/j.rce.2012.03.004. Spanish. PubMed PMID: 22534168.
AÑO: 2012; IF: 0.76
|